Akebia Therapeutics (AKBA) Inventory (2018 - 2026)
Akebia Therapeutics (AKBA) posted quarterly Inventory of $13.0 million for Q1 2026, down 34.14% year-over-year from $19.7 million in Q1 2025, and down 16.75% quarter-over-quarter from $15.6 million in Q4 2025.
Akebia Therapeutics (AKBA) Inventory (2018 - 2026) Analysis & Trends
Akebia Therapeutics (AKBA) has reported Inventory for 9 consecutive years, with $13.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Inventory fell 34.14% year-over-year to $13.0 million; the TTM figure through Mar 2026 stood at $13.0 million (down 34.14% YoY), while the FY2025 annual figure was $15.6 million, down 3.9% from the prior year.
- Inventory retreated to $13.0 million in Q1 2026 per AKBA's latest filing, from $15.6 million in the prior quarter.
- Across five years, Inventory topped out at $45.2 million in Q3 2022 and bottomed at $13.0 million in Q1 2026.
- Historically, Inventory has averaged $23.1 million across 5 years, with a median of $20.4 million in 2023.
- Annual changes were most pronounced in 2022 — Inventory surged 34.3% — and 2023, when it tumbled 59.24%.
- Akebia Therapeutics' Inventory stood at $21.6 million in 2022, then slipped by 27.25% to $15.7 million in 2023, then increased by 3.52% to $16.2 million in 2024, then retreated by 3.9% to $15.6 million in 2025, then dropped by 16.75% to $13.0 million in 2026.
- Business Quant data shows AKBA's Inventory at $13.0 million in Q1 2026, $15.6 million in Q4 2025, and $18.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 1.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 3.22 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 2.57 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 9.08 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 193.80 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 3.93 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 1.77 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 816.00 Mn |
| 10 | Akebia Therapeutics | 249.25 Mn | 93.70 Mn | 38.70 Mn | 13.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.02 Mn |
| Mar 31, 2026 | 13.00 Mn |
| Dec 31, 2025 | 15.61 Mn |
| Sep 30, 2025 | 18.64 Mn |
| Jun 30, 2025 | 16.71 Mn |
| Mar 31, 2025 | 19.73 Mn |
| Dec 31, 2024 | 16.24 Mn |
| Sep 30, 2024 | 20.49 Mn |
| Jun 30, 2024 | 23.87 Mn |
| Mar 31, 2024 | 25.53 Mn |
| Dec 31, 2023 | 15.69 Mn |
| Sep 30, 2023 | 18.44 Mn |
| Jun 30, 2023 | 20.91 Mn |
| Mar 31, 2023 | 20.41 Mn |
| Dec 31, 2022 | 21.57 Mn |
| Sep 30, 2022 | 45.24 Mn |
| Jun 30, 2022 | 40.23 Mn |
| Mar 31, 2022 | 41.10 Mn |
| Dec 31, 2021 | 36.63 Mn |
| Sep 30, 2021 | 33.69 Mn |